ANA Chronicles 40 years of Japanese Video Game History with Dedicated Content
30.10.2019 18:00:00 EET | Business Wire | Press release
All Nippon Airways (ANA), Japan’s largest 5-Star airline for seven consecutive years will launch new content, “IS JAPAN COOL? GAME CHRONICLE,” that focuses on Japanese game culture and seeks to increase awareness of Japan’s contributions to this growing industry. The content will be part of IS JAPAN COOL? website that is designed to promote international tourism in Japan. With the number of game-centric visitors to Japan on the rise, this website is a vital tool in planning travel itineraries.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191030005402/en/
"GAME CHRONICLE" (Graphic: Business Wire)
Video games are the combined product of creators’ imagination and developers’ passion. Japan has long been a trendsetter in video game design and this website offers tourists a crash course in the history of video games and their impact on Japanese culture.
“ANA seeks to act as an ambassador for Japan and its culture on the global stage, and the launch of this new website section will help drive tourism while providing an important educational resource for those interested in video games,” said Takashi Shiki, Senior Executive Vice President of ANA. “Like everything we do, IS JAPAN COOL? has always sought to set the gold standard for tourism websites, and this latest addition certainly goes above and beyond expectations. We invite all visitors to Japan by using IS JAPAN COOL? to help plan their trips.”
Available in English and Chinese, ANA first launched “IS JAPAN COOL?” in 2012 to make Japan more accessible while also introducing the nation’s unique culture and attractions to the world. In addition to its detailed explanation of Japanese culture, IS JAPAN COOL? offers local insight that helps tourists navigate during their visit to Japan. The website features insider information on cities and local prefectures including Tokyo, Okinawa, and Kyoto while providing detailed overviews of Japanese culture such as washoku (Japanese cuisine), contemporary arts, matsuri (festivals), as well as budo and geido (martial arts and performing/fine arts).
This website focuses on Japanese game history at four different stages, breaking it down by decade to highlight achievements in the 1980s, 1990s, 2000s, and 2010s and discussing 100 key topics that exemplify each of the four eras. Giving achievement points for each article read and video watched, this website itself is even structured like a video game to give visitors a memorable experience as they learn more about Japanese video games.
Each decade has a distinct theme, with image resolution and music faithfully being reproduced to evoke the technical limitations and overall aesthetic of each era. This allows visitors to learn about advances in game technology in each era.
Visitors can also watch interviews featuring prominent game experts from developers and creators sharing their behind-the-scenes stories and insider perspectives to professional gamers who offer their views on the industry today. This compelling content is available only on the “IS JAPAN COOL? GAME CHRONICLE” website.
ANA embraces its Japanese roots and is proud to celebrate the many distinct aspects of its culture and history. Video games make up one of Japan’s most important modern culture exports and ANA seeks to welcome the next generation of tourists, particularly those with an interest in video games.
About ANA
Following the “Inspiration of Japan” high quality of service, ANA has been awarded the respected 5-Star rating every year since 2013 from SKYTRAX. ANA is the only Japanese airline to win this prestigious designation seven years in a row. Additionally, ANA has been recognized by Air Transport World as “Airline of the Year” three times in the past 10 years - 2007, 2013 and 2018, becoming one of the few airlines winning this prestigious award for multiple times.
ANA was founded in 1952 with two helicopters and has become the largest airline in Japan, as well as one of the most significant airlines in Asia, operating 82 international routes and 121 domestic routes. ANA offers a unique dual hub model which enables passengers to travel to Tokyo and connect through the two airports in the metropolitan Tokyo, NARITA and HANEDA, to various destinations throughout Japan, and also offers same day connections between various North American, Asian and Chinese cities.
ANA has been a member of Star Alliance since 1999 and has joint venture partnerships with United Airlines, Lufthansa German Airlines, Swiss International Airlines and Austrian Airlines.
Besides the full service and award winner carrier ANA, the ANA Group has two LCCs as consolidated subsidiaries, Vanilla Air Inc. and Peach Aviation Limited. The ANA Group carried 54.4 million passengers in FY2018, has approximately 43,000 employees and a fleet of 260 aircrafts. ANA is a proud launch customer and the biggest operator of the Boeing 787 Dreamliner.
For more information, please refer to the following link.
https://www.ana.co.jp/group/en/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191030005402/en/
Contact information
“GAME CHRONICLE” PR Office: AUR, Inc.
Ashita Iju (Mr.), Miyabi Ishida (Ms.)
TEL: +81-3-5545-3888
E-mail: ijc_pr-ml@aur.co.jp
Or
ANA Corporate Communications, TEL +81-3-6735-1111, publicrelations@ana.co.jp
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom